Patient-patient Centered Outcomes Research

Journal Title：Patient-patient Centered Outcomes Research

The Patient provides a venue for scientifically rigorous, timely, and relevant research to promote the development, evaluation and implementation of therapies, technologies, and innovations that will enhance the patient experience. It is an international forum for research that advances and/or applies qualitative or quantitative methods to promote the generation, synthesis, or interpretation of evidence.

The journal has specific interest in receiving original research, reviews and commentaries related to qualitative and mixed methods research, stated-preference methods, patient reported outcomes, and shared decision making.

Advances in regulatory science, patient-focused drug development, patient-centered benefit-risk and health technology assessment will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in The Patient may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

All manuscripts are subject to peer review by international experts.

患者为科学严谨、及时和相关的研究提供场所，以促进疗法、技术和创新的开发、评估和实施，从而增强患者体验。它是一个国际研究论坛，推进和/或应用定性或定量方法来促进证据的生成、综合或解释。

该期刊对接收与定性和混合方法研究、陈述偏好方法、患者报告结果和共同决策相关的原创研究、评论和评论特别感兴趣。

还将考虑在监管科学、以患者为中心的药物开发、以患者为中心的利益风险和健康技术评估方面的进步。

其他数字功能（包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画）可以与文章一起发布；这些旨在提高期刊内容的知名度、读者群和教育价值。此外，在 The Patient 上发表的文章可能会附有通俗易懂的语言摘要，以帮助对该领域有一定了解但不具备深入专业知识的读者了解重要的医学进展。

所有手稿均需经过国际专家的同行评审。

Patient-patient Centered Outcomes Research创刊于2008年，由ADIS INT LTD出版商出版，收稿方向涵盖HEALTH CARE SCIENCES & SERVICES全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度>12周，或约稿，影响因子指数3.226，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。